Related Experiment Video
Updated: Apr 17, 2026
08:21
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
7.5K
The GPCR heterotetramer: challenging classical pharmacology
1Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health (NIH), Triad Technology Building, 333 Cassell Drive, Baltimore, MD 21224, USA.
Trends in Pharmacological Sciences
|February 24, 2015
Summary
New models propose G protein-coupled receptor (GPCR) oligomers, specifically GPCR heterotetramers, as functional units. This structure facilitates complex signaling interactions involving Gs and Gi proteins.
Area of Science:
- Pharmacology
- Molecular Biology
- Biochemistry
Background:
- G protein-coupled receptors (GPCRs) are crucial drug targets.
- Emerging concepts include GPCR pre-coupling and oligomerization.
- Existing models may not fully capture GPCR signaling complexity.
Purpose of the Study:
- To review evidence supporting GPCRs forming functional oligomeric complexes.
- To introduce a model of GPCR heterotetramers as signaling units.
- To explore the role of pre-coupling in GPCR-mediated signaling.
Main Methods:
- Literature review of current research on GPCR pre-coupling and oligomerization.
- Analysis of proposed models for GPCR signaling complexes.
- Examination of evidence for heterotetramer formation and function.
Main Results:
- GPCR homodimers can act as building blocks for larger complexes.
- GPCR heterotetramers provide a framework for coordinated Gs and Gi protein signaling.
- Pre-coupling of components enhances the efficiency of signaling machinery.
Conclusions:
- GPCR heterotetramers represent a promising model for understanding complex signaling.
- The pre-coupling of signaling molecules is integral to GPCR function.
- This model offers new perspectives for GPCR drug discovery and pharmacology.
Related Concept Videos
01:12GPCR Desensitization
8.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.9K
01:15G Protein-coupled Receptors
20.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
20.1K
01:09GPCRs Regulate Adenylyl Cylase Activity
8.4K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.4K
01:30Transducer Mechanism: G Protein–Coupled Receptors
8.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
8.8K
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
104
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
104
01:29Pharmacogenomics: Identification of New Drug Targets
95
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
95